Ashvattha Therapeutics

Ashvattha Therapeutics is a biotechnology company focused on developing novel therapeutics that aim to slow down or reverse the aging process. The company aims to leverage cutting-edge scientific research in the fields of genetics, cell biology, and metabolism to develop interventions that can help people live healthier, longer lives. Ashvattha Therapeutics is dedicated to developing therapies that can address age-related diseases such as cancer, cardiovascular disease, and neurodegenerative disorders. The company believes that by targeting the underlying biological processes that cause aging, they can impact multiple disease pathways at once, providing a more comprehensive approach to disease prevention and treatment.

Ashvattha Therapeutics's Investors